Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Inhibrx, Inc. Common Stock (INBX)

Biological Products, (no Disgnostic Substances)

https://www.inhibrx.com

Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.

11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/19/2020

Market Cap

179,863,107

Shares Outstanding

47,290,000

Weighted SO

47,290,666

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

CRNX --.--%

MRUS --.--%

LYEL --.--%

KRON --.--%

OPT --.--%

MLYS --.--%

ELYM --.--%

ANEB --.--%

MACK --.--%

Beta

2.8770

Last Div

0.8500

Range

10.8-18.95

Chg

0.0300

Avg Vol

193360

Mkt Cap

179863107

Exch

NASDAQ

Country

US

Phone

858 795 4220

DCF Diff

10.8807

DCF

1.3043

Div Yield

0.0684

P/S

97.0659

EV Multiple

0.1219

P/FV

0.8199

Div Yield %

6.8410

P/E

0.1101

PEG

-0.0027

Payout

0.0000

Current Ratio

6.1983

Quick Ratio

6.1983

Cash Ratio

5.8092

DSO

273.2083

DIO

0.0000

Op Cycle

273.2083

DPO

3307.3521

CCC

-3034.1438

Gross Margin

0.2245

Op Margin

-199.0496

Pretax Margin

882.6454

Net Margin

881.7636

Eff Tax Rate

0.0002

ROA

6.3227

ROE

16.1760

ROCE

-1.6814

NI/EBT

0.9990

EBT/EBIT

-4.4343

EBIT/Rev

-199.0496

Debt Ratio

0.0084

D/E

0.0099

LT Debt/Cap

0.0000

Total Debt/Cap

0.0098

Int Coverage

-12.3510

CF/Debt

-106.6209

Equity Multi

1.1780

Rec Turnover

1.3360

Pay Turnover

0.1104

Inv Turnover

0.0000

FA Turnover

0.1927

Asset Turnover

0.0072

OCF/Share

-15.9903

FCF/Share

-16.4453

Cash/Share

15.6716

OCF/Sales

-124.9185

FCF/OCF

1.0285

CF Coverage

-106.6209

ST Coverage

-106.6209

CapEx Coverage

-35.1410

Div&CapEx Cov

-35.1410

P/BV

0.8199

P/B

0.8199

P/S

97.0659

P/E

0.1101

P/FCF

-0.7555

P/OCF

-0.7770

P/CF

-0.7770

PEG

-0.0027

P/S

97.0659

EV Multiple

0.1219

P/FV

0.8199

DPS

0.8500

Latest Headlines (EST)

MarketWatch Jan 23, 08:37 Here’s what big consumer-sentiment gains mean for the stock market — and this one is unusual MarketWatch Jan 23, 06:47 Here’s what ‘vibecession’ endings usually mean for the stock market. This one is unusual anyway.

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.85 05/30/2024 11/30/-0001 05/30/2024 06/20/2024